Adaptive Biotechnologies is trading at $23.92, down 5.56%, amid broad market weakness.
- On October 22, 2026, Reuters reported technology stocks fell as mega-cap results failed to ease concerns about AI spending, while recovering oil prices added to market unease.
- Supplied market context also describes heightened geopolitical tensions and risk-off sentiment; no clear company-specific announcement explaining the decline surfaced in the search.
- The move is occurring during live trading; no current volume data was verified.